Scicinski, Jan <br/><br/>
Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent.  [electronic resource] 

 -  Drug metabolism and disposition: the biological fate of chemicals  Sep 2012 
 - 1810-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-009X 
<br/><br/><label>Standard No.: </label>10.1124/dmd.112.046755  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alkylation<br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Azetidines--administration & dosage<br/>Biotransformation<br/>Chromatography, Liquid<br/>Cysteine<br/>Dogs<br/>Erythrocytes--metabolism<br/>Haplorhini<br/>Hemoglobins--metabolism<br/>Humans<br/>Injections, Intravenous<br/>Kidney--metabolism<br/>Male<br/>Metabolic Clearance Rate<br/>Nitro Compounds--administration & dosage<br/>Peptide Mapping<br/>Protein Binding<br/>Proteomics--methods<br/>Rats<br/>Rats, Wistar<br/>Sulfhydryl Compounds--metabolism<br/>Tandem Mass Spectrometry<br/>Tissue Distribution<br/>beta-Globins--metabolism